<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02782429</url>
  </required_header>
  <id_info>
    <org_study_id>IMIP</org_study_id>
    <nct_id>NCT02782429</nct_id>
  </id_info>
  <brief_title>The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery</brief_title>
  <acronym>KeCoDy</acronym>
  <official_title>The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Flavia orange</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rebeca Gonelli Albanez da Cunha Andrade</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Materno Infantil Prof. Fernando Figueira</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the Ketamine with its anti-inflammatory profile would
      be able to prevent cognitive disorders in the postoperative period of cardiac surgery, since
      these disorders contribute to an impact on morbidity / mortality in this population.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cognitive disorder, defined by a drop of 2 points in the Mini-Mental State Examination</measure>
    <time_frame>Baseline and 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Detectable levels of inflammatory biomarkers in bloodstream, such as: P-selectin (CD62p- ng/ml), CD40L soluble (ng/ml), s100B (ng/ml)</measure>
    <time_frame>Change from baseline at 6 hours and 24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delirium assessed using the Confusion Assessment Method (CAM)</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sternotomy Pain assessed using the Visual Analogue Scale</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Delirium</condition>
  <condition>Inflammation</condition>
  <condition>Cognitive Disorders</condition>
  <condition>Amnestic</condition>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group received ketamine in a dose 0.5 mg / in anesthesia, in addition to other drugs used for induction, which will be standardized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group received the equivalent volume of saline, in addition to other drugs used for induction, which will be standardized.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 50 years.

          -  Be submitted to cardiac surgery by sternotomy and with the use of cardiopulmonary
             bypass (CPB).

          -  American Society of Anesthesiologists classification 1, 2,3 and 4.

        Exclusion Criteria:

          -  Patients undergoing reoperation.

          -  Patients undergoing heart transplantation.

          -  Patients using vasopressor agents and / or ionotropic continuous preoperatively.

          -  Patients with prior endotracheal intubation and consequently Ventilatory Assistance
             Mechanics.

          -  Patients with documented psychiatric disorders.

          -  Patients with previous cognitive disorders.

          -  Patients with a history of alcohol or drug abuse.

          -  Patients with a history of cerebrovascular accident (CVA) with less than 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebeca GA Andrade, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Medicina Integral Prof Fernando Figueira</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebeca GA Andrade, master</last_name>
    <phone>+55 81 988043844</phone>
    <email>bekinhagonelli@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto de Medicina Integral Prof Fernando Figueira</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50070-550</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fl√°via A de Orange, PhD</last_name>
      <phone>+ 55 81 994197979</phone>
      <email>orangeflavia@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Rebeca GA Andrade, master</last_name>
      <phone>+55 81 988043844</phone>
      <email>bekinhagonelli@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Hudetz JA, Iqbal Z, Gandhi SD, Patterson KM, Byrne AJ, Hudetz AG, Pagel PS, Warltier DC. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand. 2009 Aug;53(7):864-72. doi: 10.1111/j.1399-6576.2009.01978.x. Epub 2009 Apr 28.</citation>
    <PMID>19422355</PMID>
  </results_reference>
  <results_reference>
    <citation>Cata JP, Abdelmalak B, Farag E. Neurological biomarkers in the perioperative period. Br J Anaesth. 2011 Dec;107(6):844-58. doi: 10.1093/bja/aer338. Epub 2011 Nov 6. Review.</citation>
    <PMID>22065690</PMID>
  </results_reference>
  <results_reference>
    <citation>Dale O, Somogyi AA, Li Y, Sullivan T, Shavit Y. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg. 2012 Oct;115(4):934-43. Epub 2012 Jul 23. Review.</citation>
    <PMID>22826531</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2016</study_first_submitted>
  <study_first_submitted_qc>May 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2016</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Materno Infantil Prof. Fernando Figueira</investigator_affiliation>
    <investigator_full_name>Flavia orange</investigator_full_name>
    <investigator_title>Prof, Dr</investigator_title>
  </responsible_party>
  <keyword>ketamine</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Neurocognitive Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

